Apexigen Accounts Payable

Apexigen (APGN) currently reports a accounts payable of $3.4M as of June 2023. That compares with $130M in the prior-year period — down 97.5% year over year. Use the charts on this page to explore Apexigen's accounts payable history and peer comparisons.

Apexigen's accounts payable decreased from $130M to $3.4M — a 97.5% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Apexigen reported $3.4M in accounts payable as of June 2023. That compares with $130M in the prior-year period — down 97.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $3.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Apexigen, and consider following APGN for alerts when major investors trade the stock.